Rock Springs Capital Management’s Edwards Lifesciences EW Stock Holding History

Rock Springs Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.31M	Sell	28,900 -53,600	-65%	-$4.42M	0.14%	86
2025 Q4	$7.03M	Sell	82,500 -5,500	-6%	-$451K	0.36%	62
2025 Q3	$6.84M	Sell	88,000 -43,000	-33%	-$3.36M	0.4%	59
2025 Q2	$10.2M	Sell	131,000 -124,000	-49%	-$9.25M	0.64%	53
2025 Q1	$18.5M	Sell	255,000 -290,000	-53%	-$20.8M	1.06%	34
2024 Q4	$40.3M	Sell	545,000 -31,900	-6%	-$2.23M	1.54%	22
2024 Q3	$38.1M	Buy	576,900 +26,900	+5%	+$1.95M	1.24%	32
2024 Q2	$50.8M	Sell	550,000 -97,300	-15%	-$8.62M	1.53%	24
2024 Q1	$61.9M	Hold	647,300	–	–	1.57%	20
2023 Q4	$49.4M	Hold	647,300	–	–	1.22%	26
2023 Q3	$44.8M	Buy	647,300 +1,400	+0.2%	+$113K	1.2%	29
2023 Q2	$60.9M	Hold	645,900	–	–	1.45%	25
2023 Q1	$53.4M	Hold	645,900	–	–	1.27%	29
2022 Q4	$48.2M	Buy	645,900 +14,900	+2%	+$1.15M	1.16%	31
2022 Q3	$52.1M	Buy	631,000 +29,000	+5%	+$2.79M	1.35%	22
2022 Q2	$57.2M	Buy	602,000 +5,500	+0.9%	+$569K	1.67%	17
2022 Q1	$70.2M	Buy	596,500 +14,500	+2%	+$1.63M	1.77%	17
2021 Q4	$75.4M	Hold	582,000	–	–	1.74%	15
2021 Q3	$65.9M	Hold	582,000	–	–	1.39%	22
2021 Q2	$60.3M	Hold	582,000	–	–	1.19%	24
2021 Q1	$48.7M	Hold	582,000	–	–	1.06%	30
2020 Q4	$53.1M	Hold	582,000	–	–	1.13%	29
2020 Q3	$46.5M	Hold	582,000	–	–	1.18%	31
2020 Q2	$40.2M	Hold	582,000	–	–	1.1%	32
2020 Q1	$36.6M	Buy	582,000 +31,500	+6%	+$2.27M	1.51%	19
2019 Q4	$42.8M	Hold	550,500	–	–	1.35%	18
2019 Q3	$40.4M	Hold	550,500	–	–	1.61%	13
2019 Q2	$33.9M	Hold	550,500	–	–	1.23%	23
2019 Q1	$35.1M	Hold	550,500	–	–	1.35%	18
2018 Q4	$28.1M	Buy	550,500 +10,500	+2%	+$531K	1.33%	19
2018 Q3	$31.3M	Buy	540,000 +45,000	+9%	+$2.2M	1.13%	23
2018 Q2	$24M	Sell	495,000 -75,003	-13%	-$3.5M	0.92%	35
2018 Q1	$26.5M	Hold	570,003	–	–	1.13%	28
2017 Q4	$21.4M	Hold	570,003	–	–	0.97%	32
2017 Q3	$20.8M	Hold	570,003	–	–	0.96%	32
2017 Q2	$22.5M	Buy	570,003 +142,503	+33%	+$5.2M	1.13%	26
2017 Q1	$13.4M	Buy	427,500 +66,000	+18%	+$2.07M	0.77%	43
2016 Q4	$11.3M	Buy	361,500 +51,750	+17%	+$1.68M	0.76%	43
2016 Q3	$12.4M	Buy	309,750 +59,250	+24%	+$2.23M	0.78%	43
2016 Q2	$8.33M	Buy	250,500 +22,500	+10%	+$770K	0.62%	51
2016 Q1	$6.7M	Buy	+228,000	New	+$6.29M	0.56%	56
2014 Q1	–	Sell	-255,000	Closed	-$2.79M	–	78
2013 Q4	$2.79M	Buy	+255,000	New	+$2.87M	1%	29

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Rock Springs Capital Management's EW Position: Q1 2026 in Review

Rock Springs Capital Management reduced its Edwards Lifesciences (EW) stake by 65% in Q1 2026, selling an estimated $4.42M and leaving 28,900 shares worth $2.31M. The position accounts for 0.14% of the portfolio, ranked #86.

Rock Springs Capital Management first reported a position in EW in Q4 2013 and has held it in 42 quarters since. The position peaked at $75.4M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Rock Springs Capital Management held 28,900 shares of Edwards Lifesciences worth $2.31M as of Q1 2026.
Rock Springs Capital Management sold 53,600 Edwards Lifesciences shares in Q1 2026, an estimated $4.42M.
Edwards Lifesciences made up 0.14% of Rock Springs Capital Management's portfolio in Q1 2026, its #86 holding.
Rock Springs Capital Management first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 42 quarters since.
Rock Springs Capital Management's Edwards Lifesciences position peaked at $75.4M in Q4 2021.
1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Rock Springs Capital Management's 13F filing for Q1 2026, filed 15 May 2026.